• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

基于中国人群的研究:尿 miR-26b 作为脓毒症相关急性肾损伤患者的潜在生物标志物。

Urinary miR-26b as a potential biomarker for patients with sepsis-associated acute kidney injury: a Chinese population-based study.

机构信息

Clinical Laboratory, 3201 Hospital, Hanzhong, Shaanxi, China.

出版信息

Eur Rev Med Pharmacol Sci. 2018 Jul;22(14):4604-4610. doi: 10.26355/eurrev_201807_15518.

DOI:10.26355/eurrev_201807_15518
PMID:30058697
Abstract

OBJECTIVE

Acute kidney injury (AKI) is common in critically ill patients, and sepsis patients with AKI had a higher mortality rate. The aim of the present study was to determine the potential value of urinary miR-26b in the diagnosis of sepsis-associated AKI.

PATIENTS AND METHODS

Urinary samples were collected from a cohort of 155 sepsis patients (68 AKI patients and 87 non-AKI patients) and 57 patients with non-infectious systemic inflammatory response syndrome (SIRS). The expression levels of urinary miR-26b were measured by RT-qPCR analysis. ROC curve analysis was performed to determine the diagnostic value. Pearson correlation analysis was performed to assess the levels of urinary miR-26b and several clinical parameters. Kaplan-Meier curves were plotted to show the impact of urinary miR-26b on the 28-day survival.

RESULTS

Significantly increased urinary miR-26b levels were found in patients with sepsis-associated AKI. Urinary miR-26b had a sensitivity of 90.8% and specificity of 75.0% for distinguishing between AKI sepsis and non-AKI sepsis. Urinary miR-26b levels were closely correlated with clinical parameters reflecting the severity of the disease. Kaplan-Meier analysis revealed that sepsis patients with high urinary miR-26b levels had an elevated mortality rate.

CONCLUSIONS

Taken together, these findings suggested that urinary miR-26b might be utilized as a potential biomarker for sepsis-associated AKI.

摘要

目的

急性肾损伤(AKI)在危重症患者中较为常见,且伴有 AKI 的脓毒症患者死亡率更高。本研究旨在探讨尿 miR-26b 在诊断脓毒症相关性 AKI 中的潜在价值。

患者与方法

本研究纳入了 155 例脓毒症患者(68 例 AKI 患者和 87 例非 AKI 患者)和 57 例非感染性全身炎症反应综合征(SIRS)患者的尿液样本。采用 RT-qPCR 分析检测尿 miR-26b 的表达水平。通过 ROC 曲线分析评估其诊断价值。采用 Pearson 相关分析评估尿 miR-26b 与多项临床参数的相关性。绘制 Kaplan-Meier 曲线以显示尿 miR-26b 对 28 天生存率的影响。

结果

与非 AKI 脓毒症患者相比,伴有 AKI 的脓毒症患者的尿 miR-26b 水平显著升高。尿 miR-26b 用于鉴别 AKI 脓毒症和非 AKI 脓毒症的敏感性为 90.8%,特异性为 75.0%。尿 miR-26b 水平与反映疾病严重程度的临床参数密切相关。Kaplan-Meier 分析显示,尿 miR-26b 水平较高的脓毒症患者死亡率较高。

结论

综上所述,这些发现表明尿 miR-26b 可能可作为脓毒症相关性 AKI 的潜在生物标志物。

相似文献

1
Urinary miR-26b as a potential biomarker for patients with sepsis-associated acute kidney injury: a Chinese population-based study.基于中国人群的研究:尿 miR-26b 作为脓毒症相关急性肾损伤患者的潜在生物标志物。
Eur Rev Med Pharmacol Sci. 2018 Jul;22(14):4604-4610. doi: 10.26355/eurrev_201807_15518.
2
Discovery and validation of miR-452 as an effective biomarker for acute kidney injury in sepsis.发现并验证 miR-452 作为脓毒症急性肾损伤的有效生物标志物。
Theranostics. 2020 Oct 25;10(26):11963-11975. doi: 10.7150/thno.50093. eCollection 2020.
3
Deregulated microRNA-22-3p in patients with sepsis-induced acute kidney injury serves as a new biomarker to predict disease occurrence and 28-day survival outcomes.在脓毒症诱导的急性肾损伤患者中,失调的 microRNA-22-3p 可作为一种新的生物标志物,用于预测疾病发生和 28 天的生存结局。
Int Urol Nephrol. 2021 Oct;53(10):2107-2116. doi: 10.1007/s11255-021-02784-z. Epub 2021 Jan 28.
4
Plasma Neutrophil Gelatinase-Associated Lipocalin diagnosed acute kidney injury in patients with systemic inflammatory disease and sepsis.血浆中性粒细胞明胶酶相关脂质运载蛋白可诊断全身性炎症疾病和脓毒症患者的急性肾损伤。
Nephrology (Carlton). 2017 May;22(5):412-419. doi: 10.1111/nep.12796.
5
Urinary actin, as a potential marker of sepsis-related acute kidney injury: A pilot study.尿肌动蛋白作为脓毒症相关急性肾损伤的潜在标志物:一项初步研究。
PLoS One. 2021 Jul 26;16(7):e0255266. doi: 10.1371/journal.pone.0255266. eCollection 2021.
6
Diagnostic performance of urinary kidney injury molecule-1 and neutrophil gelatinase-associated lipocalin for acute kidney injury in an obstructive nephropathy patient.尿肾损伤分子 1 和中性粒细胞明胶酶相关脂质运载蛋白对梗阻性肾病患者急性肾损伤的诊断性能。
Nephrology (Carlton). 2014 Apr;19(4):186-94. doi: 10.1111/nep.12173.
7
A promising marker in early diagnosis of septic acute kidney injury of critically ill patients: urine insulin like growth factor binding protein-7.危重症患者脓毒症急性肾损伤早期诊断的一个有前景的标志物:尿胰岛素样生长因子结合蛋白-7
Scand J Clin Lab Invest. 2016 Sep;76(5):402-10. doi: 10.1080/00365513.2016.1187765. Epub 2016 May 31.
8
The Potential of miR-370-3p and miR-495-3p Serving as Biomarkers for Sepsis-Associated Acute Kidney Injury.miR-370-3p 和 miR-495-3p 作为脓毒症相关性急性肾损伤生物标志物的潜力。
Comput Math Methods Med. 2022 Jul 11;2022:2439509. doi: 10.1155/2022/2439509. eCollection 2022.
9
A Pilot Study Identifying a Set of microRNAs As Precise Diagnostic Biomarkers of Acute Kidney Injury.一项确定一组微小RNA作为急性肾损伤精确诊断生物标志物的初步研究。
PLoS One. 2015 Jun 16;10(6):e0127175. doi: 10.1371/journal.pone.0127175. eCollection 2015.
10
Expression patterns and prognostic value of miR-210, miR-494, and miR-205 in middle-aged and old patients with sepsis-induced acute kidney injury.miR-210、miR-494 和 miR-205 在中老年脓毒症相关性急性肾损伤患者中的表达模式及预后价值。
Bosn J Basic Med Sci. 2019 Aug 20;19(3):249-256. doi: 10.17305/bjbms.2019.4131.

引用本文的文献

1
A Systematic Review and Meta-Analysis of MicroRNA as Predictive Biomarkers of Acute Kidney Injury.微小RNA作为急性肾损伤预测生物标志物的系统评价与Meta分析
Biomedicines. 2024 Jul 30;12(8):1695. doi: 10.3390/biomedicines12081695.
2
Insights into non-coding RNAS: biogenesis, function and their potential regulatory roles in acute kidney disease and chronic kidney disease.非编码RNA研究进展:生物合成、功能及其在急性肾损伤和慢性肾脏病中的潜在调控作用
Mol Cell Biochem. 2025 Mar;480(3):1287-1304. doi: 10.1007/s11010-024-05083-0. Epub 2024 Aug 7.
3
MicroRNAs as Biomarkers and Therapeutic Targets for Acute Kidney Injury.
微小RNA作为急性肾损伤的生物标志物和治疗靶点
Diagnostics (Basel). 2023 Sep 9;13(18):2893. doi: 10.3390/diagnostics13182893.
4
MicroRNA Profiles in Critically Ill Patients.危重症患者的 microRNA 谱。
Curr Med Chem. 2024;31(41):6801-6825. doi: 10.2174/0929867331666230726095222.
5
MicroRNAs in septic acute kidney injury.脓毒症急性肾损伤中的微小RNA
Burns Trauma. 2023 Mar 20;11:tkad008. doi: 10.1093/burnst/tkad008. eCollection 2023.
6
Expression of MicroRNAs in Sepsis-Related Organ Dysfunction: A Systematic Review.脓毒症相关器官功能障碍中 MicroRNAs 的表达:系统评价。
Int J Mol Sci. 2022 Aug 19;23(16):9354. doi: 10.3390/ijms23169354.
7
Modes of action and diagnostic value of miRNAs in sepsis.miRNAs 在脓毒症中的作用机制和诊断价值。
Front Immunol. 2022 Aug 5;13:951798. doi: 10.3389/fimmu.2022.951798. eCollection 2022.
8
MicroRNAs in kidney injury and disease.微小 RNA 与肾脏损伤和疾病
Nat Rev Nephrol. 2022 Oct;18(10):643-662. doi: 10.1038/s41581-022-00608-6. Epub 2022 Aug 16.
9
Machine learning for the prediction of acute kidney injury in patients with sepsis.机器学习在脓毒症患者急性肾损伤预测中的应用。
J Transl Med. 2022 May 13;20(1):215. doi: 10.1186/s12967-022-03364-0.
10
Non-Coding RNAs in Sepsis-Associated Acute Kidney Injury.脓毒症相关性急性肾损伤中的非编码RNA
Front Physiol. 2022 Apr 8;13:830924. doi: 10.3389/fphys.2022.830924. eCollection 2022.